Curbstone Financial Management Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$710K Sell
1,416
-50
-3% -$24K 0.12% 150
2026
Q1
$721K Sell
1,466
-100
-6% -$54.3K 0.14% 138
2025
Q4
$907K Buy
1,566
+310
+25% +$175K 0.17% 118
2025
Q3
$609K Sell
1,256
-110
-8% -$51.2K 0.12% 147
2025
Q2
$554K Buy
1,366
+50
+4% +$20.9K 0.11% 157
2025
Q1
$655K Hold
1,316
0.14% 140
2024
Q4
$685K Buy
+1,316
New +$724K 0.15% 138

Other funds holding TMO

Curbstone Financial Management Corp's TMO Position: Q2 2026 in Review

Curbstone Financial Management Corp reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2026, selling an estimated $24K and leaving 1,416 shares worth $710K. The position accounts for 0.12% of the portfolio, ranked #150.

Curbstone Financial Management Corp first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $907K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Curbstone Financial Management Corp held 1,416 shares of Thermo Fisher Scientific worth $710K as of Q2 2026.
  • Curbstone Financial Management Corp sold 50 Thermo Fisher Scientific shares in Q2 2026, an estimated $24K.
  • Thermo Fisher Scientific made up 0.12% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #150 holding.
  • Curbstone Financial Management Corp first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Curbstone Financial Management Corp's Thermo Fisher Scientific position peaked at $907K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.